Esomeprazole Magnesium DR

Nexium

Strengths & Sizes

Esomeprazole Magnesium DR
Esomeprazole Magnesium DR

Note: product and packaging images are not actual size

  • NDC#31722-664-30
  • UPC Code331722664301
  • ImprintE2/H
Esomeprazole Magnesium DR
Esomeprazole Magnesium DR

Note: product and packaging images are not actual size

  • NDC#31722-664-90
  • UPC Code331722664905
  • ImprintE2/H
Esomeprazole Magnesium DR
Esomeprazole Magnesium DR

Note: product and packaging images are not actual size

  • NDC#31722-664-10
  • UPC Code331722664103
  • ImprintE2/H
Esomeprazole Magnesium DR
Esomeprazole Magnesium DR

Note: product and packaging images are not actual size

  • NDC#31722-665-30
  • UPC Code331722665308
  • ImprintE3/H
Esomeprazole Magnesium DR
Esomeprazole Magnesium DR

Note: product and packaging images are not actual size

  • NDC#31722-665-90
  • UPC Code331722665902
  • ImprintE3/H
Esomeprazole Magnesium DR
Esomeprazole Magnesium DR

Note: product and packaging images are not actual size

  • NDC#31722-665-10
  • UPC Code331722665100
  • ImprintE3/H

Indications

Esomeprazole magnesium delayed-release capsules are a proton pump inhibitor (PPI). Esomeprazole magnesium delayed-release capsules are indicated for the: • Short-term treatment in the healing of erosive esophagitis (EE) in adults and pediatric patients 12 years to 17 years of age. • Maintenance of healing of EE in adults. • Short-term treatment of heartburn and other symptoms associated GERD in adults and pediatric patients 12 years to 17 years of age. • Risk reduction of nonsteroidal anti-inflammatory drugs (NSAID)-associated gastric ulcer in adults at risk for developing gastric ulcers due to age (60 years and older) and/or documented history of gastric ulcers. • Helicobacter pylori eradication in adult patients to reduce the risk of duodenal ulcer recurrence in combination with amoxicillin and clarithromycin. • Long-term treatment of pathological hypersecretory conditions, including Zollinger-Ellison syndrome in adults.